Healthy HIV-1-infected individuals on highly active antiretroviral therapy harbor HIV-1 in their alveolar macrophages

AIDS Research and Human Retroviruses

Volumn 31, Issue 1, 2015, Pages 64-70

  Cribbs, Sushma K ^a,b   Lennox, Jeffrey ^b   Caliendo, Angela M ^c   Brown, Lou Ann ^b   Guidot, David M ^a,b  

^a Affairs Medical Center   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; ABACAVIR PLUS LAMIVUDINE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ATAZANAVIR; ATAZANAVIR PLUS RITONAVIR; CIGARETTE SMOKE; DARUNAVIR; EFAVIRENZ; EMTRICITABINE; ETRAVIRINE; FLUORESCEIN ISOTHIOCYANATE; LAMIVUDINE PLUS ZIDOVUDINE; LOPINAVIR PLUS RITONAVIR; RALTEGRAVIR; RITONAVIR; TENOFOVIR; VIRUS DNA; VIRUS RNA;

ADULT; ARTICLE; ASSAY; BRONCHOSCOPY; CLINICAL ARTICLE; CROSS-SECTIONAL STUDY; FEMALE; FLUORESCENCE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; LUNG; LUNG ALVEOLUS MACROPHAGE; LUNG INFECTION; LUNG LAVAGE; MALE; PHAGOCYTOSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; STAPHYLOCOCCUS AUREUS; VIRUS LOAD; VIRUS REPLICATION; BLOOD; BRONCHOALVEOLAR LAVAGE FLUID; CYTOLOGY; GENETICS; HIV INFECTIONS; IMMUNOLOGY; MIDDLE AGED; PROVIRUS; VIROLOGY;

ADULT; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BRONCHOALVEOLAR LAVAGE FLUID; CROSS-SECTIONAL STUDIES; DNA, VIRAL; FEMALE; HIV INFECTIONS; HUMANS; MACROPHAGES, ALVEOLAR; MALE; MIDDLE AGED; PHAGOCYTOSIS; PROSPECTIVE STUDIES; PROVIRUSES; RNA, VIRAL; STAPHYLOCOCCUS AUREUS; VIRAL LOAD; VIRUS REPLICATION;

EID: 84928958835     PISSN: 08892229     EISSN: 19318405     Source Type: Journal    
DOI: 10.1089/aid.2014.0133     Document Type: Article

References (33)

1. El-Sadr WM, Lundgren JD, Neaton JD, et al.: CD4 + countguided interruption of antiretroviral treatment. N Engl J Med 2006;355(22):2283-2296
2. Gordin FM, Roediger MP, Girard PM, et al.: Pneumonia in HIV-infected persons: Increased risk with cigarette smoking and treatment interruption. Am J Respir Crit Care Med 2008;178(6):630-636
3. Jordano Q, Falco V, Almirante B, et al.: Invasive pneumococcal disease in patients infected with HIV: Still a threat in the era of highly active antiretroviral therapy. Clin Infect Dis 2004;38(11):1623-1628
4. Crothers K, Huang L, Goulet JL, et al.: HIV infection and risk for incident pulmonary diseases in the combination antiretroviral therapy era. Am J Respir Crit Care Med 2011;183(3):388-395
5. Murphy J, Summer R, Wilson AA, Kotton DN, and Fine A: The prolonged life-span of alveolar macrophages. Am J Respir Cell Mol Biol 2008;38(4):380-385
6. Tan J and Sattentau QJ: The HIV-1-containing macrophage compartment: A perfect cellular niche?. Trends Microbiol 2013;21(8):405-412
7. Joshi PC, Raynor R, Fan X, and Guidot DM: HIV-1-transgene expression in rats decreases alveolar macrophage zinc levels and phagocytosis. Am J Respir Cell Mol Biol 2008;39(2):218-226
8. Joshi PC and Guidot DM: HIV-1 transgene expression in rats induces differential expression of tumor necrosis factor alpha and zinc transporters in the liver and the lung. AIDS Res Ther 2011;8:36
9. Pugliese A, Vidotto V, Beltramo T, and Torre D: Phagocytic activity in human immunodeficiency virus type 1 infection. Clin Diagn Lab Immunol 2005;12(8):889-895
10. Furtado MR, Callaway DS, Phair JP, et al.: Persistence of HIV-1 transcription in peripheral-blood mononuclear cells in patients receiving potent antiretroviral therapy. N Engl J Med 1999;340(21):1614-1622
11. Wong JK, Hezareh M, Gunthard HF, et al.: Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. Science 1997;278(5341):1291-1295
12. Zhang L, Ramratnam B, Tenner-Racz K, et al.: Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy. N Engl J Med 1999; 340(21):1605-1613
13. Chun TW, Davey RT, Jr, Engel D, Lane HC, and Fauci AS: Re-emergence of HIV after stopping therapy. Nature 1999;401(6756):874-875
14. Chun TW, Davey RT, Jr, Ostrowski M, et al.: Relationship between pre-existing viral reservoirs and the re-emergence of plasma viremia after discontinuation of highly active anti-retroviral therapy. Nat Med 2000;6(7):757-761
15. Davey RT, Jr., Bhat N, Yoder C, et al.: HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression. Proc Natl Acad Sci USA 1999;96(26): 15109-15114
16. Park IW, Koziel H, Hatch W, et al.: CD4 receptor-dependent entry of human immunodeficiency virus type-1 envpseudotypes into CCR5-, CCR3-, and CXCR4-expressing human alveolar macrophages is preferentially mediated by the CCR5 coreceptor. Am J Respir Cell Mol Biol 1999; 20(5):864-871
17. Agostini C, Trentin L, Zambello R, and Semenzato G: HIV-1 and the lung. Infectivity, pathogenic mechanisms, and cellular immune responses taking place in the lower respiratory tract. Am Rev Respir Dis 1993;147(4):1038-1049
18. Alimohammadi A, Coker R, Miller R, et al.: Genotypic variants of HIV-1 from peripheral blood and lungs of AIDS patients. AIDS 1997;11(6):831-832
19. Itescu S, Simonelli PF, Winchester RJ, and Ginsberg HS: Human immunodeficiency virus type 1 strains in the lungs of infected individuals evolve independently from those in peripheral blood and are highly conserved in the C-terminal region of the envelope V3 loop. Proc Natl Acad Sci USA 1994;91(24):11378-11382
20. Clarke JR, Gates AJ, Coker RJ, et al.: HIV-1 proviral DNA copy number in peripheral blood leucocytes and bronchoalveolar lavage cells of AIDS patients. Clin Exp Immunol 1994;96(2):182-186
21. Koziel H, Kim S, Reardon C, et al.: Enhanced in vivo human immunodeficiency virus-1 replication in the lungs of human immunodeficiency virus-infected persons with Pneumocystis carinii pneumonia. Am J Respir Crit Care Med 1999;160(6):2048-2055
22. Twigg HL, Soliman DM, Day RB, et al.: Lymphocytic alveolitis, bronchoalveolar lavage viral load, and outcome in human immunodeficiency virus infection. Am J Respir Crit Care Med 1999;159(5 Pt 1):1439-1444
23. Denis M and Ghadirian E: Alveolar macrophages from subjects infected with HIV-1 express macrophage inflammatory protein-1 alpha (MIP-1 alpha): Contribution to the CD8 + alveolitis. Clin Exp Immunol 1994;96(2):187-192
24. Evans MR and Wansbrough-Jones MH: Alveolar macrophage activation in HIV infection. J Infect 1996;33(2):91-94
25. Koziel H, ORiordan D, Warner A, and Rose RM: Alveolar macrophage interaction with Pneumocystis carinii. Immunol Ser 1994;60:417-436
26. Buhl R, Jaffe HA, Holroyd KJ, et al.: Activation of alveolar macrophages in asymptomatic HIV-infected individuals. J Immunol 1993;150(3):1019-1028
27. Day RB, Wang Y, Knox KS, et al.: Alveolar macrophages from HIV-infected subjects are resistant to Mycobacterium tuberculosis in vitro. Am J Respir Cell Mol Biol 2004; 30(3):403-410
28. Elssner A, Carter JE, Yunger TM, and Wewers MD: HIV-1 infection does not impair human alveolar macrophage phagocytic function unless combined with cigarette smoking. Chest 2004;125(3):1071-1076
29. Gordon SB, Jagoe RT, Jarman ER, et al.: The alveolar microenvironment of patients infected with human immunodeficiency virus does not modify alveolar macrophage interactions with Streptococcus pneumoniae. Clin Vaccine Immunol 2013;20(6):882-891
30. Koziel H, Eichbaum Q, Kruskal BA, et al.: Reduced binding and phagocytosis of Pneumocystis carinii by alveolar macrophages from persons infected with HIV-1 correlates with mannose receptor downregulation. J Clin Invest 1998;102(7):1332-1344
31. Musher DM, Watson DA, Nickeson D, et al.: The effect of HIV infection on phagocytosis and killing of Staphylococcus aureus by human pulmonary alveolar macrophages. Am J Med Sci 1990;299(3):158-163
32. Jambo KC, Banda DH, Kankwatira AM, et al.: Small alveolar macrophages are infected preferentially by HIV and exhibit impaired phagocytic function. Mucosal Immunol 2014;7(5):1116-1126
33. Reardon CC, Kim SJ, Wagner RP, Koziel H, and Kornfeld H: Phagocytosis and growth inhibition of Cryptococcus neoformans by human alveolar macrophages: Effects of HIV-1 infection. AIDS 1996;10(6):613-618